Your browser doesn't support javascript.
loading
Intraoperative radiotherapy-containing multidisciplinary management of trunk-wall soft-tissue sarcomas
Sole, CV; Calvo, FA; Cambeiro, M; Polo, A; Montero, A; Hernanz, R; Gonzalez, C; Cuervo, M; Perez, D; Julian, MS; Martinez-Monge, R.
Afiliação
  • Sole, CV; Hospital General Universitario Gregorio Marañón. Madrid. Spain
  • Calvo, FA; Hospital General Universitario Gregorio Marañón. Madrid. Spain
  • Cambeiro, M; Clínica Universidad de Navarra. Pamplona. Spain
  • Polo, A; Hospital Universitario Ramón y Cajal. Madrid. Spain
  • Montero, A; Hospital Universitario Ramón y Cajal. Madrid. Spain
  • Hernanz, R; Hospital Universitario Ramón y Cajal. Madrid. Spain
  • Gonzalez, C; Hospital General Universitario Gregorio Marañón. Madrid. Spain
  • Cuervo, M; Hospital General Universitario Gregorio Marañón. Madrid. Spain
  • Perez, D; Hospital Universitario Ramón y Cajal. Madrid. Spain
  • Julian, MS; Clínica Universidad de Navarra. Pamplona. Spain
  • Martinez-Monge, R; Clínica Universidad de Navarra. Pamplona. Spain
Clin. transl. oncol. (Print) ; 16(9): 834-842, sept. 2014.
Artigo em Inglês | IBECS | ID: ibc-126575
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT

PURPOSE:

A joint analysis of data from centers within the intraoperative radiotherapy (IORT)-Spanish cooperative initiative was performed to investigate the main contributions of IORT to the multidisciplinary treatment of trunk-wall soft-tissue sarcoma (TW-STS). MATERIALS AND

METHODS:

Patients with a histologic diagnosis of TW-STS (primary tumor 53 %; locally recurrent 47 %) with absence of distant metastases, undergoing surgery with radical intent and IORT (median dose 12.5 Gy) were considered eligible for participation in this study. In addition, all primary tumors received external-beam radiotherapy (median dose 50 Gy).

RESULTS:

From 1986 to 2012, a total of 68 patients were analyzed in the study from three Spanish institutions. With a median follow-up time of 53 months (range 4-316), 5-year local control (LC) was 58 %. Five-year IORT in-field control, disease-free survival (DFS) and overall survival were 70, 45 and 51 %, respectively. On multivariate analysis, only microscopically involved margin (R1) resection status retained significance in relation to LC (HR 3.97, p < 0.001). In regard to IORT in field control, incomplete resection (HR 3.23, p = 0.008) and recurrent disease status (HR 2.52, p = 0.04) retained a significant association in multivariate analysis.

CONCLUSION:

From this joint analysis emerges the fact that margin and disease status influences local and central control, but DFS remains modest, given the high risk of distant metastases. Intensified local treatment needs to be tested in the context of more efficient concurrent, neo-, and adjuvant systemic therapy (AU)
RESUMEN
No disponible
Assuntos
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Sarcoma / Radioterapia Adjuvante Limite: Feminino / Humanos / Masculino Idioma: Inglês Revista: Clin. transl. oncol. (Print) Ano de publicação: 2014 Tipo de documento: Artigo Instituição/País de afiliação: Clínica Universidad de Navarra/Spain / Hospital General Universitario Gregorio Marañón/Spain / Hospital Universitario Ramón y Cajal/Spain
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Sarcoma / Radioterapia Adjuvante Limite: Feminino / Humanos / Masculino Idioma: Inglês Revista: Clin. transl. oncol. (Print) Ano de publicação: 2014 Tipo de documento: Artigo Instituição/País de afiliação: Clínica Universidad de Navarra/Spain / Hospital General Universitario Gregorio Marañón/Spain / Hospital Universitario Ramón y Cajal/Spain
...